Try GOLD - Free
GLP-1 launches inject over 2x rise in India's weight-loss market sales in '25
Business Standard
|January 08, 2026
Mounjaro tops revenue charts, recording ₹601 cr in sales within 9 months of launch
India’s anti-obesity market saw a significant growth in 2025 with sales surging 115 per cent on year, as new launches in the injectable glucagon-like peptide-1 (GLP-1) agonist space, such as tirzepatide and semaglutide, flew off the shelves.
Sales in the weight loss market soared to ₹1,230 crore in 2025, against ₹571 crore in 2024.
GLP-1 agonists are a class of medications that help regulate blood sugar, increase fullness (satiety), and slow stomach emptying, leading to weight loss and improved glucose control for type 2 diabetes and obesity. Among them, Eli Lilly’s Mounjaro (tirzepatide) topped the revenue charts, recording ₹601 crore in sales within nine months of its launch in March 2025, while Novo Nordisk’s Wegovy (semaglutide) saw overall sales of ₹61 crore in six months.
On the other hand, Ozempic, launched only last month in India has raked in ₹1 crore.
This story is from the January 08, 2026 edition of Business Standard.
Subscribe to Magzter GOLD to access thousands of curated premium stories, and 10,000+ magazines and newspapers.
Already a subscriber? Sign In
MORE STORIES FROM Business Standard
Business Standard
Netflix's India decade: From 'HBO moment' to a hunt for mass reach
More than 16 million subscribers, about 50 million viewers and close to%4,000 crore in revenues.
3 mins
January 10, 2026
Business Standard
'FY27 Budget should focus on consumption demand, boosting income'
Budget 2026-27 must focus on improving consumption demand and give a legup to micro, small and medium enterprises (MSMEs), especially to tide over global uncertainties, Nirmal K Minda, Assocham president and executive chairman of UNO Minda, tells Ruchika Chitravanshi in an interview in New Delhi.
2 mins
January 10, 2026
Business Standard
Working well with Venezuela: Trump cancels 2nd attack
US Prez set to outline plan for Venezuelan oil
2 mins
January 10, 2026
Business Standard
Air as an electoral issue
Cyclones in Odisha, landslides in Uttarakhand, floods in Assam, pollution in Delhi.
3 mins
January 10, 2026
Business Standard
Darjeeling tea output may have hit a new low in 2025
The famed Darjeeling tea may have slipt to a new production low in 2025, as changing weather patterns, a shortage of pluckers and mounting economic stress weigh on the region’s gardens.
2 mins
January 10, 2026
Business Standard
Oil & gas industry expects GST relief, LPG under-recovery compensation
‘The oil and gas industry expects the upcoming Union Budget to address compensation for underrecoveries on the sale of cooking gas cylinders and provide goods and services tax (GST) relief for exploration activities, say experts.
1 min
January 10, 2026
Business Standard
Competition may weigh on power equipment firms
Their stocks fell for a second day amid reports about possible removal of curbs on China companies bidding for govt contracts
2 mins
January 10, 2026
Business Standard
Groww faces proxy advisory pushback over Esop, board nomination proposals
Proxy advisory firm Institutional Investor Advisory Services (IiAS) has recommended against all five resolutions proposed by Billionbrains Garage Ventures Limited, the parent company of Groww, citing governance and transparency concerns.
1 mins
January 10, 2026
Business Standard
Worst week in over 3 months for indices amid new tariff fears
Weakness in equity mkts
1 min
January 10, 2026
Business Standard
Sumadhura group to invest ₹1K cr to launch 6 projects in Bengaluru
Bengaluru-based real estate developer Sumadhura group has rolled out six luxury residential projects, committing %1,000 crore in investment with an estimated revenue potential of %10,000 crore.
1 min
January 10, 2026
Listen
Translate
Change font size